Ramagiri Sruthi, Taliyan Rajeev
J Basic Clin Physiol Pharmacol. 2016 Jan;27(1):1-8. doi: 10.1515/jbcpp-2015-0021.
Hydroxy safflor yellow A (HSYA) has been translated clinically for cardiovascular diseases. HSYA is also greatly acknowledged for its protective effects against cerebral ischemic-reperfusion (I/R) injury. Although the precise mechanism of cerebral I/R injury is not fully understood, oxygen-derived free radicals and mitochondrial permeability transition pore (mPTP) opening during I/R injury are widely recognized as an important contributor to neuronal injury. Thus, we speculated that the neuroprotective effects of HSYA against cerebral I/R injury may be associated with mPTP modulation.
Induction of I/R injury was achieved by 60 min of middle cerebral artery occlusion, followed by reperfusion for 24 h. For behavior and cognitive assessment, neurological scoring (NSS), rotarod, and Y-maze task were performed. Oxidative damage was measured in terms of markers such as malondialdehyde, reduced glutathione, and catalase levels and cerebral infarct volumes were quantified using 2,3,5-triphenyl tetrazolinium chloride staining. I/R injury-induced inflammation was determined using tumor necrosis factor-α (TNF-α) levels.
Animals exposed to I/R injury showed neurological severity, functional and cognitive disability, elevated oxidative markers, and TNF-α levels along with large infarct volumes. HSYA treatment during onset of reperfusion ameliorated performance in NSS, rotarod and Y-maze attenuated oxidative damage, TNF-α levels, and infarction rate. However, treatment with carboxyatractyloside, an mPTP opener, 20 min before HSYA, attenuated the protective effect of HSYA.
Our study confirmed that protective effect of HSYA may be conferred through its free radical scavenger action followed by inhibiting the opening of mPTP during reperfusion and HSYA might act as a promising therapeutic agent against cerebral I/R injury.
羟基红花黄色素A(HSYA)已应用于心血管疾病的临床治疗。HSYA对脑缺血再灌注(I/R)损伤的保护作用也得到了广泛认可。尽管脑I/R损伤的确切机制尚未完全明确,但I/R损伤期间氧自由基和线粒体通透性转换孔(mPTP)开放被广泛认为是神经元损伤的重要原因。因此,我们推测HSYA对脑I/R损伤的神经保护作用可能与mPTP调节有关。
通过大脑中动脉闭塞60分钟,然后再灌注24小时诱导I/R损伤。进行行为和认知评估时,采用神经评分(NSS)、转棒试验和Y迷宫试验。通过丙二醛、还原型谷胱甘肽、过氧化氢酶水平等指标检测氧化损伤,并使用2,3,5-三苯基氯化四氮唑染色定量脑梗死体积。使用肿瘤坏死因子-α(TNF-α)水平测定I/R损伤诱导的炎症反应。
遭受I/R损伤的动物表现出神经功能严重程度、功能和认知障碍、氧化指标升高、TNF-α水平升高以及梗死体积增大。再灌注开始时给予HSYA治疗可改善NSS、转棒试验和Y迷宫试验中的表现,减轻氧化损伤、TNF-α水平和梗死率。然而,在HSYA给药前20分钟用mPTP开放剂羧基苍术苷治疗可减弱HSYA的保护作用。
我们的研究证实,HSYA的保护作用可能通过其自由基清除作用,随后抑制再灌注期间mPTP的开放来实现,HSYA可能是一种有前景的抗脑I/R损伤治疗药物。